Enterprise Financial Services Corp Neurocrine Biosciences Inc Transaction History

Enterprise Financial Services Corp

  • $177 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $4,807 - $7,280
-64 Closed
0 $0
Q3 2019

Oct 31, 2019
SELL
$83.82 - $101.5 $502,919 - $609,000
-6,000 Reduced 98.94%
64 $6,000
Q1 2019

Apr 26, 2019
BUY
$69.31 - $91.53 $415,860 - $549,180
6,000 Added 9375.0%
6,064 $535,000
Q3 2018

Oct 26, 2018
BUY
$98.88 - $125.85 $6,328 - $8,054
64 New
64 $8,000

Others Institutions Holding NBIX

# of Institutions
655
Shares Held
96.7M
Call Options Held
316K
Put Options Held
300K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email